The Safeguarded AI programme is said to transform the safety of AI by integrating scientific models with mathematical proofs.

Following a successful Type B end-of-phase 2 meeting, the FDA has approved the start of a phase 3 trial of linperlisib in peripheral T-cell lymphoma.

A University of Iowa-led study has revealed the unexpected structure adopted by the DNA repair protein RAD52 as it binds and protects replicating DNA in dividing cells. This new structural and ...

Mirvetuximab soravtansine improved overall survival, progression-free survival, second progression-free survival, and other outcomes.

Phase III VERITAC-2 trial results show vepdegestrant significantly improved progression-free survivalcompared to fulvestrant ...

Phase III IMvoke010 trial found that maintenance treatment with Tecentriq (atezolizumab) did not significantly improve survival compared with placebo in patients with locally advanced squamous cell ...

This section spotlights 41 of Cleveland’s exceptional litigators and trial attorneys whose expertise and commitment to justice sets them apart in the legal community. They come from firms big and ...

The strategy of the camp of former president Rodrigo Duterte is very clear this early. They will turn the International Criminal Court (ICC) trial of Duterte into a double trial: first, as a criminal ...

On Tuesday, the KwaZulu-Natal High Court in Durban heard that her trial would begin in November. Pre-trial proceedings are set for mid-August, the NPA said. The trial of Duduzile Zuma-Sambudla on ...

At 5 p.m. on March 20, if you happen to be on the Poonamallee Bypass, look up, and you will witness the trial run of Chennai Metro Rail’s three-coach train. This will be the first time the train ...

How do the primary analysis results of the MIRASOL trial differ from the primary analysis results? Were there any unexpected findings? Back then, when we did the primary analysis, we had a follow ...

Toon Van Gorp, MD, PhD, discussed findings from the MIRASOL trial and the potential of mirvetuximab to redefine treatment paradigms in ovarian cancer. Mirvetuximab soravtansine-gynx (Elahere) ...